What is the disposable circumcision anastomat/stapler and how does the bell-and-staple mechanism actually fire?
A disposable circumcision anastomat—commonly referred to in clinical literature and hospital tenders as a disposable circumcision suture device (DCSD) or circular circumcision stapler—is a factory-sterilized, single-use surgical instrument designed for redundant prepuce excision and immediate anastomosis 7. Historically, urological surgeons performed male circumcision using conventional scalpel excision, dorsal-slit dissection, electrocautery hemostasis, and manual placement of 8 to 16 interrupted absorbable sutures. While effective, conventional open surgery requires roughly 20 to 30 minutes of operative time, produces variable cosmetic margins, and carries risks of post-operative edema, hematoma, and needle-stick injuries.
The circular circumcision stapler replaces manual dissection and suturing with a single mechanical pass. To understand how the device operates, biomedical engineers and clinical buyers must evaluate its seven core mechanical components:
- Inner Glans Bell (Glans Shield / Anvil): A smooth, domed stainless steel or high-rigidity polymer bell sized to fit over the glans penis. It protects the urethral meatus and corona from accidental blade contact while serving as the anvil rim against which micro-staples are formed.
- Connecting Rod & Adjusting Knob: A threaded central shaft passing through the core of the instrument. Turning the distal adjusting knob pulls the inner bell tightly against the outer housing, clamping the prepuce at a precise, pre-set tissue gap.
- Outer Main Housing & Ergonomic Handle: The primary body of the instrument, typically molded from medical-grade polycarbonate or ABS, featuring an ergonomic handgrip and a safety firing lever.
- Annular Cutting Blade (Circular Scalpel): A ultra-sharp, cylindrical stainless steel blade mounted concentric to the staple driving ring. Upon trigger actuation, the blade moves forward milliseconds before or simultaneously with staple deployment to cleanly sever excess foreskin.
- Staple Firing Ring & Pushers: A circular array of molded plastic pushers positioned behind a circumferential cartridge loaded with 14 to 32 fine micro-staples.
- Micro-Staples (Suture Pins): Fine wire staples manufactured from implant-grade pure titanium (ASTM F67 Grade 1/2) or stainless steel (316LVM). The staples feature sharp bevel tips and are coated with a silicone-elastomer gasket or silicone rubber washer that maintains uniform compression along the wound edge.
- Safety Firing Pin & Lock: A physical mechanical lockout lever that prevents accidental trigger actuation until the adjusting knob has fully clamped the tissue to the specified thickness indicator.
The mechanical firing sequence follows a strict four-stage kinematic progression:
Stage 1 — Sizing & Anvil Positioning: After local anesthesia and dorsal nerve block, the operator uses a dedicated sizing gauge to select the exact glans bell diameter (ranging from 10 mm pediatric sizes to 34 mm adult extra-large sizes). The inner bell is inserted beneath the foreskin to shield the glans completely.
Stage 2 — Prepuce Traction & Tissue Clamping: The foreskin is pulled evenly over the outer rim of the glans bell using prepuce forceps. The operator connects the bell shaft to the main housing rod and rotates the distal adjusting knob. This draws the bell into the outer housing, compressing the inner and outer mucosal and cutaneous prepuce layers into a uniform clamp gap of 0.8 mm to 1.2 mm.
Stage 3 — Trigger Actuation & Simultaneous Cut-and-Staple: Disengaging the safety pin allows the surgeon to squeeze the firing handle. Mechanical force (typically 30 N to 65 N) drives the annular cutting blade forward to sever the foreskin while the pusher ring ejects the micro-staples through the tissue. The staple legs strike the concave pockets of the stainless steel anvil rim, bending each staple legs inward to form a rigid, closed 'B' shape. The silicone washer acts as a resilient cushion, maintaining capillary hemostasis along the anastomotic line.
Stage 4 — Release & Post-Operative Shedding: The operator backs off the adjusting knob, detaches the inner bell from the wound margin, and removes the instrument. The entire firing procedure takes under 60 seconds of active mechanical manipulation. Over the subsequent 7 to 21 days, as the incised wound edge heals via primary intention, the silicone gasket undergoes micro-degradation, and the micro-staples spontaneously detach and fall away into the dressing, eliminating the need for manual suture removal.
Understanding this mechanical distinction is essential for distributors and urology buyers comparing circular staplers against self-detaching rings. For detailed guidance on matching adult versus pediatric sizing ladders across both product lines, refer to our companion analysis on adult and pediatric circumcision device sizing and portfolio selection.
What goes in a circumcision anastomat kit, and which item is the regulated medical device versus the accessory consumables?
In high-volume hospital operating rooms and outpatient surgical centers, purchasing agents rarely acquire the circular stapler as a bare standalone instrument. Instead, procurement specifications demand a single-use, sterile convenience pack known as a Circumcision Anastomat Kit 1. Bundling all necessary procedural consumables into a single sterile blister pack eliminates intraoperative delays, standardizes sterile field preparation, and simplifies inventory control.
However, biomedical engineering departments and quality auditors must clearly distinguish between the primary regulated medical device within the kit and the accessory surgical consumables. The table below details the standard component architecture of a professional circumcision anastomat convenience pack:
| Component Name | Functional Role in Procedure | Regulatory Tier & Standards | Inspection / QA Parameter |
|---|---|---|---|
| Disposable Circumcision Anastomat / Stapler | Primary surgical instrument for circular foreskin excision and mechanical staple anastomosis. | Regulated Class II Medical Device (21 CFR 884.4530 / NMPA Class II). Primary device registration holder. | Staple formation, anvil concentricity, blade sharpness, firing force, trigger safety lockout. |
| Circumcision Sizing Gauge / Tape | Graduated measuring strip or circular caliber card for determining glans coronal diameter. | Medical Device Accessory / Class I exempt tool. | Dimensional print calibration accuracy (±0.2 mm), edge smoothness, non-toxic print ink. |
| Prepuce Forceps (Hemostatic Clamps) | Surgical forceps (typically 2 to 3 units) to grasp and position foreskin over the glans bell. | Class I Surgical Instrument (ISO 7153-1 stainless steel or reinforced polymer). | Jaw alignment, ratchet locking force, absence of burrs or sharp flash. |
| Self-Adhesive Elastic Cohesive Bandage | Post-operative compression wrap applied over silicone staple ring to control edema and bleeding. | Class I General Hospital Consumable / Medical Textile. | Cohesive adhesion strength, breathability, hypoallergenic skin contact validation. |
| Sterile Gauze Sponges / Petroleum Dressing | Wound cleaning, blood absorption, and non-adherent wound protection beneath elastic wrap. | Class I sterile gauze and dressing (EN 14079 absorbent gauze; EN 13726 wound-dressing tests). | Absorbency, linting/fiber release limit, sterile barrier package integrity. |
| Skin Disinfectant Swabsticks / Iodine Prep | Pre-operative surgical site antisepsis of penis, scrotum, and suprapubic area. | Topical Antiseptic / Drug or Medical Device depending on jurisdiction (FDA OTC drug / NMPA Hygiene). | Active chemical concentration, pouch seal integrity, fluid volume retention. |
| Surgical Scalpel / Tie-Off Thread | Auxiliary scalpel blade for frenular relief cuts or absorbable suture for arterial tie-off if required. | Class I / II Surgical Consumable (ISO 7740 scalpel blade). | Blade sharpness, suture tensile strength, needle sharpness. |
Source: VEMERIX Product Engineering & FDA Convenience Kits Guidance Specification, 2026.
From a regulatory compliance standpoint, packaging multiple medical devices and surgical consumables into a single kit creates a convenience pack. In the United States, convenience kits are governed under the FDA's May 20, 1997 Interim Regulatory Guidance on Convenience Kits and product code OHG (Circumcision Tray) 1. Under these rules, if all individual components in the kit are legally marketed Class I or Class II devices that are not re-sterilized or modified during assembly, the kit packager may market the tray without submitting a separate 510(k) premarket notification for the combination.
In contrast, under the European Union Medical Device Regulation (EU MDR 2017/745 Article 22) and China NMPA regulations, a procedure kit packager must issue a formal Article 22 declaration or hold a combined Class II medical device registration certificate (e.g., NMPA Reg. 20162020372 for VEMERIX Anastomat Kits). Distributors sourcing bulk kits must ensure that the master packaging label explicitly lists the legal manufacturer, sterile batch number, ethylene oxide sterilization expiration date, and individual component traceability.
For procurement teams negotiating commercial terms, volume minimums, and shipping packaging for complete kits, refer to our detailed breakdown on normalizing circumcision device quotes and modeling landed cost.
How does the FDA product-code taxonomy place this device (QQR vs HFX clamp vs OHG tray) — and why are there no US stapler clearances?
A common point of confusion for regulatory affairs personnel and international importers is how the US Food and Drug Administration classifies circumcision instruments. Circumcision devices are categorized under 21 CFR 884.4530 (Obstetric-gynecologic specialized manual instrument) within the Obstetrics and Gynecology device panel 1. However, the FDA classification database assigns distinct three-letter product codes based on the specific mechanical action of the device.
To establish an authoritative baseline, VEMERIX conducted a comprehensive extraction of the openFDA 510(k) Premarket Notification database (175,559 records, snapshot 20260724_export_current), openFDA Device Classification database, and openFDA MAUDE Adverse Event database across all receive-years 3. The results reveal a striking regulatory landscape summarized in Table 2 below:
| Product Code | Device Classification Title | Device Mechanical Type | FDA Class & Panel | 510(k) Clearances (Count) | MAUDE Event Reports (Count) |
|---|---|---|---|---|---|
| QQR | Circumcision Device With Stapler | Circular cut-and-staple anastomat deploying metallic micro-staples. | Class II (21 CFR 884.4530) OB/GYN | 0 | 0 |
| HFX | Clamp, Circumcision | Ischemic compression clamp / collar ring (Gomco, Plastibell, ShangRing). | Class II (21 CFR 884.4530) OB/GYN | 27 | 852 |
| FHG | Bell, Circumcision | Standalone glans protection bell / anvil component. | Class II (21 CFR 884.4530) OB/GYN | 2 | 42 |
| FHJ | Shield, Circumcision | Protective surgical guard shield. | Class II (21 CFR 884.4530) OB/GYN | 2 | 0 |
| OHG | Circumcision Tray | Sterile procedure convenience pack containing circumcision tools. | Class II (21 CFR 884.4530) OB/GYN | 0 | 49 |
Source: openFDA 510(k), Classification, and MAUDE Datasets, analysed by VEMERIX, 9 August 2026.
The empirical data demonstrates a fundamental regulatory insight: Product code QQR (Circumcision Device With Stapler) has exactly ZERO FDA 510(k) clearances and ZERO post-market MAUDE adverse event reports in the entire history of the US FDA database 3. In contrast, product code HFX (Clamp, Circumcision) accounts for 27 cleared 510(k) submissions (including major commercial predicates such as the Gomco clamp, Plastibell, and the ShangRing under K121789 and K131373) and 852 MAUDE adverse event records.
Why does product code QQR exhibit zero US clearances despite the global popularity of circumcision staplers in Asia, Europe, and Latin America? The explanation lies in regulatory economics and predicate history:
- Absence of an Eligible Substantial Equivalence Predicate: Because no manufacturer submitted and cleared a circular circumcision stapler prior to the 1976 Medical Device Amendments, any vendor seeking US clearance under code QQR cannot file a standard 510(k) citing a predicate. Sponsoring a US market entry would require either a costly De Novo classification petition or a full Premarket Approval (PMA) clinical trial.
- Geographic Demand Differences: Neonatal circumcision in the US is overwhelmingly performed using Class II clamps (Gomco/Plastibell under code HFX) or Class I manual surgical instruments. Adult circumcision in the US is a low-volume ambulatory procedure, leading Asian stapler manufacturers to focus registration investments on NMPA (China), CE MDR (Europe), and regional Latin American / Middle Eastern clearances.
- Misinterpretation of Zero MAUDE Reports: Quality managers must note that zero MAUDE reports for QQR do not prove superior device safety or zero clinical failure rates. MAUDE is a passive surveillance database capturing events from devices legally marketed in the US. Because no QQR devices are commercially cleared in the US, no US healthcare facilities submit MAUDE reports for them. Zero MAUDE reflects a US documentation void, not clinical immunity.
Additionally, regulatory staff must avoid a common misclassification trap regarding general surgical staplers. On October 8, 2021, the FDA issued a final order reclassifying surgical staplers for internal use from Class I to Class II under 21 CFR 878.4740 (product code GAG) 8. However, that regulation applies strictly to general surgical staplers used in gastrointestinal, thoracic, and gynecologic internal tissue resection. Circular circumcision staplers remain categorized under obstetric-gynecologic regulation 21 CFR 884.4530 (code QQR), not Part 878.
To understand how supplier auditing and registration document verification operate outside the US market, review our guide on qualifying the circumcision device manufacturer and controlling registration documents.
Which lot-acceptance tests confirm a circumcision stapler is fit to use (staple formation, firing force, sterile barrier, EO residuals)?
Because disposable circumcision staplers operate without a US 510(k) clearance or WHO prequalification safety net, incoming quality control (IQC) by distributors and biomedical engineering acceptance testing by hospitals represent the primary defense against clinical failures. Sourcing teams cannot rely on generic certificates of analysis (CoA); they must mandate batch-specific lot acceptance testing against defined mechanical and physical thresholds.
Table 3 outlines the comprehensive lot-acceptance testing framework required for disposable circumcision staplers and sterile kits:
| Test Domain | Target Inspection Parameter | Reference Standard | Acceptance Criteria & Pass Threshold |
|---|---|---|---|
| Staple Geometry & Formation | Closed staple height, leg crimp symmetry, B-form closure angle. | Internal QA benchmark (calibrated optical comparator) | 100% of fired micro-staples must achieve closed B-form height of 1.0 mm to 1.5 mm without leg crossing or open 'U' gaps. |
| Glans Bell Concentricity | Anvil outer diameter tolerance, radial clearance, shaft coaxiality. | ISO 286-2 (Geometrical Product Specs) | Bell outer diameter tolerance within ±0.15 mm; radial gap between bell and blade housing uniform within 0.08 mm. |
| Blade Sharpness & Cut Integrity | Annular knife penetration force, tissue shear margin quality. | ISO 7153-1 / Penetration Force Test | Circular knife cut force < 25 N; 360-degree complete tissue severance without hanging tissue tags or burred edges. |
| Trigger Firing Force & Safety Lock | Peak actuation force, safety lockout torque resistance. | Calibrated force-gauge mechanical testing | Actuation force between 30 N and 65 N; safety lock must resist accidental trigger pull up to 15 N without firing. |
| Staple Wire Biocompatibility | Chemical purity, corrosion resistance, tissue reactivity of micro-staples. | ASTM F67 (unalloyed titanium) / ASTM F138 (316L stainless) | Unalloyed titanium Grade 1/2 or 316LVM stainless steel; 100% pass on ISO 10993-5 cytotoxicity testing. |
| Sterile Barrier Package Integrity | Blister pouch seal peel strength, dye penetration seal continuity. | ISO 11607-1/2, ASTM F88, ASTM F1929 | Peel strength 1.5 N/15mm to 4.5 N/15mm; zero dye penetration across heat seal channel under ASTM F1929. |
| Ethylene Oxide (EO) Residuals | Residual ethylene oxide gas and ethylene chlorohydrin (ECH) limits. | ISO 10993-7 (Sterilization Residuals) | EO residual < 4.0 mg/device; ECH residual < 9.0 mg/device after standard aeration period. |
Source: VEMERIX Quality Assurance Protocol & Standard ISO Test Specifications, 2026.
Biomedical engineers performing batch sampling should pay special attention to staple formation testing. In factory QA protocols, sample instruments from each production lot are fired into synthetic polyurethane tissue models (density 20 to 30 kg/m³) that mimic the combined thickness of human penile skin and mucosal prepuce (1.5 mm total compressed thickness). A calibrated optical comparator evaluates the resulting staple line: every micro-staple must bend cleanly into a closed B-shape. If staples exhibit an open 'U' configuration, the staple ring will fail to maintain capillary hemostasis, resulting in intraoperative bleeding.
Likewise, sterile-barrier testing cannot be overlooked. Because circumcision kits contain both plastic instruments and absorbent gauze, packaging must undergo rigorous seal strength (ASTM F88) and dye penetration (ASTM F1929) testing. For an in-depth analysis of sterile packaging validation standards, read our guide on sterile barrier and shelf-life validation for single-use devices. For complete compliance parameters governing ethylene oxide aeration and chemical residual testing, consult our reference on ethylene oxide sterilization validation and residuals for single-use devices.
What do the Cochrane review and stapler meta-analyses actually establish — and what are the staple-specific failure modes to inspect against?
When evaluating disposable circumcision staplers, procurement committees must separate clinical reality from vendor marketing. Vendors frequently claim that circular staplers 'eliminate all surgical risks' or are 'clinically superior in every outcome'. A rigorous synthesis of peer-reviewed evidence reveals a more nuanced clinical picture.
The authoritative baseline for device-based circumcision is the 2022 Cochrane Systematic Review (BJU International) 5. Analyzing randomized controlled trials comparing device-assisted circumcision against conventional surgical techniques in adolescent and adult males, Cochrane reviewers concluded that device-based circumcisions show no increase in serious adverse events compared to standard surgery. However, the overall certainty of evidence was downgraded due to risk of bias in trial unblinding, and devices demonstrated a slight increase in moderate adverse events (primarily mild edema and delayed healing).
To compare the circular stapler specifically against collar-clamp devices (such as the ShangRing), a major meta-analysis published in Revista Internacional de Andrologia 6 and prospective RCTs by Jin et al. 7 provide head-to-head quantitative metrics, summarized in Table 4:
| Outcome (comparison basis) | Pooled effect estimate (95% CI) | Direction for the stapler | Source |
|---|---|---|---|
| Wound infection (stapler vs ShangRing) | RR 0.16 (0.06–0.38) | Significantly fewer infections with the stapler | Meta-analysis (2017) |
| Wound edema (stapler vs ShangRing) | RR 0.24 (0.19–0.29) | Significantly less edema with the stapler | Meta-analysis (2017) |
| Wound dehiscence (stapler vs ShangRing) | RR 0.36 (0.21–0.62) | Significantly less dehiscence with the stapler | Meta-analysis (2017) |
| Overall adverse events (stapler vs ShangRing) | RR 0.42 (0.32–0.56) | Significantly fewer total adverse events with the stapler | Meta-analysis (2017) |
| Wound healing time (stapler vs ShangRing) | MD −8.92 days (−10.79 to −7.05) | Faster healing with the stapler | Meta-analysis (2017) |
| Intraoperative blood loss (stapler vs ShangRing) | MD +0.12 mL (0.02–0.22) | Small but statistically significant increase for the stapler — the staple-gap hemostasis trade-off | Meta-analysis (2017) |
| Postoperative bleeding (stapler vs ShangRing) | MD 2.42 (1.06–5.49); overall-effect P = 0.66 | No statistically significant difference between the device families | Meta-analysis (2017) |
| Operative time (stapler vs conventional surgery) | 6.8 min vs 24.2 min (879-men RCT) | Stapler markedly faster than conventional surgery | Jin et al. (2015) |
| Blood loss (stapler vs conventional surgery) | 1.8 mL vs 9.4 mL | Stapler markedly less blood loss than conventional surgery | Jin et al. (2015) |
| Total complications (stapler vs conventional surgery) | 2.7% vs 7.8% | Stapler fewer complications than conventional surgery | Jin et al. (2015) |
| Serious adverse events (device-based vs surgery, all device types) | No increase vs surgery; certainty downgraded | Devices not proven superior; possibly slightly more moderate adverse events | Cochrane (2022) |
Source: DCSD-vs-ShangRing meta-analysis, Revista Internacional de Andrología (2017); Jin et al. RCT, PMC4470318 (2015); Cochrane Review (2022).
Read at face value, the meta-analysis favors the stapler on almost every wound complication: significantly lower wound infection (RR 0.16), post-operative edema (RR 0.24), wound dehiscence (RR 0.36), and overall adverse-event rate (RR 0.42) relative to the ShangRing, alongside faster healing, lower 24-hour pain, and higher cosmetic satisfaction 6. The one exception is hemostasis: the disposable suture device showed a small but statistically significant increase in intraoperative blood loss versus the ShangRing (mean difference 0.12 mL, 95% CI 0.02–0.22), which the authors attribute to the residual gap left between the suture staples and the absence of electrocautery 6. Postoperative bleeding showed no statistically significant difference between the two device families — the meta-analysis reports an overall-effect P of 0.66 and its discussion states the difference did not reach significance, despite an internally inconsistent forest-plot caption 6. For the stapler versus conventional scalpel surgery, the largest randomized trial (879 men) confirms the expected advantages — 6.8 versus 24.2 minutes operative time, 1.8 versus 9.4 mL blood loss, and 2.7% versus 7.8% total complications 7 — consistent with the Cochrane finding that device-based circumcision shows no increase in serious adverse events, with overall certainty of evidence downgraded 5.
The one trade-off the pooled evidence supports — marginally higher intraoperative blood loss for the stapler versus the ShangRing, attributed to the gap left between the staples and the absence of electrocautery 6 — is exactly why staple formation belongs at the top of a lot-acceptance protocol rather than on a vendor-marketing checklist. When a micro-staple fails to close into a clean B-shape, or the glans bell sits off-center against the anvil, the staple line cannot seal the mucosal vessels and intraoperative seepage rises. Inspect each lot for these four device-specific failure modes:
- Incomplete Staple Bending (Open 'U' Staples): If anvil clearance is loose or trigger firing force is inadequate, micro-staples fail to form a closed B-shape. The unsealed mucosal vessels bleed under arterial pressure post-operatively.
- Staple Line Dislodgement / Premature Shedding: If the silicone cushion gasket is too brittle or degrades prematurely within 48 hours, micro-staples dislodge before fibrin bridging occurs, causing wound dehiscence.
- Frenular Vessel Shear: The frenular artery at the ventral aspect of the penis is thicker and under higher pressure than dorsal preputial skin. If the stapler lacks a dedicated frenular relief clearance, staples may cut through the vessel without achieving hemostasis.
- Asymmetric Glans Bell Compression: If the connecting rod tilts during knob tightening, tissue compression becomes asymmetric, leaving one quadrant undertightened and prone to hematoma.
To review how these clinical trade-offs shaped the historical market transition away from manual open surgery, read our deep-research analysis on the broader shift from scalpel-and-suture to single-use circumcision devices.
Why is the ShangRing FDA-cleared and WHO-prequalified while the stapler is not, and what does that mean for VMMC versus commercial procurement?
A decisive strategic boundary in global urology procurement is the distinction between commercial hospital procurement and public health VMMC procurement. Procurement officers often ask why the ShangRing collar-clamp device holds both US FDA 510(k) clearance and WHO Prequalification status, while circular circumcision staplers hold neither.
The World Health Organization (WHO) established its Prequalification of Male Circumcision Devices program to support Voluntary Medical Male Circumcision (VMMC) programs for HIV prevention across 13 priority countries in Eastern and Southern Africa, funded by PEPFAR, UNAIDS, and the CDC 4, 9. To date, the WHO has prequalified exactly two circumcision device families:
- The PrePex Device (Circ MedTech): An elastic collar compression ring prequalified in 2013 (later phased out due to rare tetanus risk guidelines requiring tetanus immunization pre-requisites).
- The ShangRing Device (Wuhu Snnda Medical Treatment Appliance Technology Co., Ltd.): A two-ring collar-clamp device prequalified in 2015 under Public Report
PQMC 0003-003-00, indicated for adolescent and adult males aged 13 years and older across 18 size codes 4.
The WHO prequalification process evaluates devices specifically for non-surgeon mid-level healthcare workers (nurses and clinical officers) operating in rural, resource-constrained field clinics without sterile operating theaters or electricity. Collar-clamp devices like the ShangRing were chosen for VMMC because they require zero sharp blade manipulation during placement and zero metallic staples.
In contrast, circular circumcision staplers deploy an internal surgical blade and metallic staples. They require trained medical officers or urologists working in clean ambulatory surgical settings with local infiltration anesthesia. Because stapler manufacturers targeted commercial hospital markets in China, Europe, Latin America, and the Middle East—where primary intention healing and rapid recovery are prioritized—they did not apply for WHO VMMC prequalification.
For procurement managers, this creates a clear market boundary:
- VMMC / Public Health Tenders: Tenders funded by PEPFAR, Global Fund, or national health ministries for HIV prevention programs strictly mandate WHO Prequalification. In this channel, the ShangRing or manual surgical kits are legally required.
- Commercial Hospital & Outpatient Urology Procurement: Private hospitals, ambulatory surgical centers, and commercial distributor networks operate under national medical device registrations (such as CE MDR in Europe, NMPA Class II in China, or regional health authority approvals). In this channel, circular staplers dominate due to superior cosmetic outcomes, lower infection rates, and high patient satisfaction.
Where VEMERIX fits — and where due diligence still begins
As the international brand of Weihai Medison Medical Equipment Co., Ltd., VEMERIX occupies a established position in urology surgical consumables, backed by NMPA-registered manufacturing facilities and ISO 13485 quality management systems.
The VEMERIX urology portfolio provides international buyers with a balanced, multi-tier product line:
- Circumcision Anastomat Kit (NMPA Lu Mech Reg. 20162020372): Class II sterile convenience packs available in Adult and Children kit configurations, pre-bundling the circular anastomat with sizing tools, prep forceps, and dressings.
- Disposable Circumcision Stapler (NMPA Lu Mech Reg. 20192020192): Single-pass cut-and-staple circular instruments featuring titanium micro-staples and precision glans bell shields.
- Auto-Circumcision Ring (NMPA Lu Mech Reg. 20172020238, CE Marked): Sutureless, self-detaching circumcision ring platform spanning 14 adult and pediatric size codes.
- Disposable Sterile Circumcision Device (NMPA Lu Mech Reg. 20222021157): One-step factory-sterilized outpatient device optimized for high-throughput ambulatory surgery.
VEMERIX supports distributor partners by providing full technical documentation packs, including NMPA registration certificates, ISO 13485 QMS audit reports, ISO 11607 sterile-barrier validation summaries, and ISO 10993-7 ethylene oxide residual test certificates. However, VEMERIX maintains a strict commitment to regulatory transparency: we do not claim US 510(k) clearance under product code QQR or WHO prequalification for circular staplers, as no manufacturer holds those credentials.
We invite international urology distributors, private-label OEM buyers, and hospital procurement committees to initiate technical evaluation. To request a comprehensive sample pack, product specifications, or regulatory evidence dossier, contact our engineering team via the VEMERIX contact portal or explore our complete line of minimally invasive surgical consumables.
Frequently Asked Questions
Q1: Is the disposable circumcision stapler the same device as the ShangRing?
No. The disposable circumcision stapler (DCSD) and the ShangRing represent fundamentally different mechanical categories. The stapler is a single-pass instrument that severs foreskin with an internal circular blade while simultaneously placing a ring of titanium micro-staples for immediate primary wound closure. The ShangRing is a two-piece plastic collar clamp that compresses foreskin against an inner ring, inducing ischemic tissue necrosis over 7 to 14 days until the ring is removed or detaches. Furthermore, the ShangRing is classified under FDA code HFX and is WHO-prequalified, whereas the stapler is categorized under code QQR and is not WHO-prequalified.
Q2: Is the disposable circumcision stapler FDA-cleared or on the US market?
According to openFDA 510(k) database analysis (snapshot current to August 2026), product code QQR (Circumcision Device With Stapler) has zero 510(k) clearances. No circular circumcision stapler holds a cleared US 510(k) predicate. Devices sold internationally operate under CE MDR, NMPA Class II, or regional health authority registrations in Europe, Asia, Latin America, and the Middle East.
Q3: What staple-related failure modes should I check each lot for during incoming inspection?
Incoming quality control must test sample units for four critical failure modes: (1) incomplete staple bending (open 'U' staples resulting from loose anvil clearance or low firing force), (2) glans bell outer diameter concentricity variations exceeding ±0.15 mm, (3) excessive trigger actuation force exceeding 65 N, and (4) blade dullness causing incomplete circumferential tissue cut.
Q4: What components belong in a circumcision anastomat kit convenience pack?
A standard sterile convenience kit contains: the Class II circular stapler, a calibrated glans sizing tape or gauge card, 2 to 3 prepuce forceps (hemostatic clamps), sterile gauze sponges, petroleum or non-adherent dressing, self-adhesive elastic cohesive compression wrap, and skin disinfectant swabsticks. In the US, convenience kits are governed under FDA product code OHG.
Q5: Is the disposable circumcision stapler WHO-prequalified for voluntary medical male circumcision (VMMC) programs?
No. The WHO List of Prequalified Male Circumcision Devices includes only collar-clamp / elastic compression devices (specifically the ShangRing and historical PrePex). Circular staplers are designed for commercial hospital and ambulatory urology surgical settings and are not prequalified for rural VMMC field programs.